MOUNTAIN VIEW, Calif., Oct. 28, 2009 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the third quarter ended September 30, 2009 after the NASDAQ Market closes on Tuesday, November 3, 2009.
